跳至主要内容
临床试验/ACTRN12611001132932
ACTRN12611001132932招募中4 期

A pilot prospective randomized open-label blinded endpoint trial of guided antiplatelet therapy with different doses of aspirin versus clopidogrel versus metformin to reduce urinary thromboxane metabolite production in aspirin resistant people with type 2 diabetes

RMIT University0 个研究点目标入组 400 人开始时间: 2011年10月28日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Impaired fasting glucose IFG (110 – 125 mg / dL) or;
  • Impaired glucose tolerance IGT (140 – 199 mg / dL) or;
  • Type-2 diabetes (IFG > 135 mg / dL or IGT > 200 mg / dL)

排除标准

  • salicylate or thienopyridine allergy or intolerance, history of haemorrhagic stroke, aneurysm or any stroke < 3 months, any thienopyridine < 3 days, history of low platelet count, history of bleeding diathesis, clinical findings in the judgement of the investigator associated with increased risk of bleeding, oral anticoagulation or other antiplatelet therapy, history of withdrawal from study due to non-compliance with medication, any condition associated with poor treatment compliance, including alcoholism, mental illness, or drug dependence, investigative site personnel directly affiliated with the study or immediate family, presently enrolled in another drug study, women who are known to be pregnant, have given birth within the past 90 days, or are breast feeding, concomitant medical illness that in the opinion of the investigator is associated with reduced survival over the expected treatment period, known severe hepatic dysfunction, planned travel or other reason why participant might be unable to cooperate with protocol requirements during the study medication period.

研究者

相似试验

已完成
不适用
A randomized open-label blinded prospective study designed to compare the efficacy and safety between once-weekly and daily administration of alendronate in patients with corticosteroid-induced osteoporosisCorticosteroid-induced osteoporosis
JPRN-UMIN000001082Keio University130
已完成
3 期
A randomized open-labelled controlled prospective study to investigate the effect of inactive iodine and lithium carbonate on radioiodine therapy in patients with Graves&#39; diseaseGraves&#39disease
JPRN-UMIN000001087Hiroshima University Hospital Department of Endocrinology and Metabolism120
招募中
不适用
A clinical trial to examine an improvement of implantation with an administration of Hishi extract.Infertility
JPRN-UMIN000045017Women&#39;s Clinic Jinno210
招募中
3 期
A large-scale trial testing the intensity of CYTOreductive therapy to prevent cardiovascular events In patients with Polycythemia Vera (PV)polycythemia veraTo assess the benefit/risk profile of cytoreductive therapy with phlebotomy and/or hydroxyurea (HU) aimed at maintaining hematocrit (HCT) < 45% Vs. maintaining HCT in the range of 45-50% in patients with PV treated at the best of recommended therapies (e.g., low dose of aspirin when indicated and adequated control of standard cardiovascular risk factors)Blood - Haematological diseases
ACTRN12609000046202Consorzio Mario Negri Sud1,000
尚未招募
不适用
To compare between honey dressing, insulin dressing and normal saline dressing as to which dressing heals the wound faster.
CTRI/2022/11/047284All India Institute of Medical Sciences, Nagpur